No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /

No. 801 - 900 Paclitaxel Patents:

	PAT. NO.		Title
801	5,907,042		Intermediates and methods useful in the semisynthesis of paclitaxel and analogs
802	5,906,990		Taxoids, preparation thereof, and pharmaceutical compositions containing same
803	5,902,822		7-methylthiooxomethyl and 7-methylthiodioxomethyl paclitaxels
804	5,902,817		Certain sulfoxide and sulfone derivatives
805	5,900,429		Method for inhibiting the growth of cancers
806	5,892,063		Cephalomannine epoxide, its analogues and a method for preparing the same
807	5,886,026		Anti-angiogenic compositions and methods of use
808	5,882,679		Liposomes containing active agents aggregated with lipid surfactants
809	5,880,131		High molecular weight polymer-based prodrugs
810	5,880,112		Naaladase inhibitors
811	5,877,210		Phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferation
812	5,877,205		Parenteral paclitaxel in a stable non-toxic formulation
813	5,874,595		Method for the preparation of baccatin III and derivatives thereof from 10-deacetylbaccatin III
814	5,874,481		Fluorochemical solutions for the delivery of lipophilic pharmaceutical agents
815	5,874,402		Use of cell membrane permeants in the treatment of cellular proliferative diseases
816	5,869,650		Dendroamide compounds and their use in chemosensitizing multidrug resistant cells
817	5,869,535		Method and composition for selectively inhibiting melanoma
818	5,869,127		Method of providing a substrate with a bio-active/biocompatible coating
819	5,863,536		Phosphoramidate derivatives
820	5,861,406		Treatment and prevention of neoplasms with salts of aminoimidazole carboxamide and 5-amino or substituted amino 1,2,3-triazoles
821	5,861,175		Use of fluorocarbons for diagnosis and treatment of articular disorders
822	5,856,351		Artemisinin dimer compounds having anticancer activity
823	5,854,408		Process for acylating the 1-position of saccharides
824	5,854,382		Bioresorbable compositions for implantable prostheses
825	5,854,278		Preparation of chlorinated paclitaxel analogues and use thereof as antitumor agents
826	5,854,231		Pharmaceutical composition for inhibiting the growth of cancers
827	5,849,691		Peptidomimetic inhibitors of cathepsin D and plasmepsins I and II
828	5,846,998		Use of phosphotyrosine phosphatase inhibitors or phosphotyrosine kinase activators for controlling cellular proliferation
829	5,846,565		Controlled local delivery of chemotherapeutic agents for treating solid tumors
830	5,840,930		Method for production of 2", 3" dihalocephalomannine
831	5,840,929		C4 methoxy ether derivatives of paclitaxel
832	5,840,925		Trioxane dimer compounds having antiproliferative and antitumor activities
833	5,840,900		High molecular weight polymer-based prodrugs
834	5,840,750		Discodermolide compounds
835	5,840,748		Dihalocephalomannine and methods of use therefor
836	5,840,673		Insulin-like growth factor binding protein 3 (IGF-BP3) in treatment of p53-related tumors
837	5,840,319		Biological agent compositions
838	5,830,697		P-glycoprotein mutant resistant to cyclosporin modulation
839	5,827,533		Liposomes containing active agents aggregated with lipid surfactants
840	5,827,532		Method for loading lipsomes with ionizable phosphorylated hydrophobic compounds, pharmaceutical preparations and a method for administering the preparations
841	5,824,701		Taxane-based prodrugs
842	5,821,263		Sulfenamide taxane derivatives
843	5,817,867		Reduction and resolution methods for the preparation of compounds useful as intermediates for preparing taxanes
844	5,817,321		Biological agent compositions
845	5,814,335		Sphingosomes for enhanced drug delivery
846	5,811,452		Taxoid reversal agents for drug-resistance in cancer chemotherapy and pharmaceutical compositions thereof
847	5,811,399		Pharmaceutical dipeptide compositions and methods of use thereof: immunodepressants
848	5,808,113		Preparation of Taxol and docetaxel through primary amines
849	5,808,102		Phosphorus bearing taxanes intermediates
850	5,807,888		Preparation of brominated paclitaxel analogues and their use as effective antitumor agents

851	5,807,830		Method for treatment of purulent inflammatory diseases
852	5,804,602		Methods of cancer treatment using naaladase inhibitors
853	5,801,191		Taxoids
854	5,795,909		DHA-pharmaceutical agent conjugates of taxanes
855	5,795,877		Inhibitors of NAALADase enzyme activity
856	5,783,178		Polymer linked biological agents
857	5,780,653		Nitrophenyl, 10-deacetylated substituted taxol derivatives as dual functional cytotoxic/radiosensitizers
858	5,780,432		Therapeutic method for treatment of carcinoma or autoimmune diseases
859	5,780,054		Methods for increasing the circulation half-life of protein-based therapeutics
860	5,777,104		Cephem derivatives as anti-metastatic agents
861	5,776,939		Drug resistance and multidrug resistance modulators
862	5,776,925		Methods for cancer chemosensitization
863	5,776,486		Methods and apparatus for making liposomes containing hydrophobic drugs
864	5,773,464		C-10 epoxy taxanes
865	5,773,461		7-deoxy-6-substituted paclitaxels
866	5,770,576		Pharmaceutical dipeptide compositions and methods of use thereof: systemic toxicity
867	5,770,430		Cellular injury response element and uses thereof
868	5,767,297		Taxoid derivative and method of producing thereof
869	5,760,251		Taxol process and compounds
870	5,760,072		Paclitaxel prodrugs, method for preparation as well as their use in selective chemotherapy
871	5,756,537		Regime for paclitaxel in Kaposi's sarcoma patients
872	5,750,737		Method for paclitaxel synthesis
873	5,750,736		Method for acylating 10-deacetylbaccatin III selectively at the c-10 position
874	5,750,562		10-deacetylbaccatine III and 10-deacetyl 14.beta.-hydroxybaccatine III derivatives, a process for the preparation thereof and pharmaceutical compositions containing them
875	5,744,460		Combination for treatment of proliferative diseases
876	5,741,516		Sphingosomes for enhanced drug delivery
877	5,739,359		Methods for preparing 1-deoxy paclitaxels
878	5,736,129		Flow cytometric pharmacosensitivity assay and method of cancer treatment
879	5,733,526		Hydrocarbon oil/fluorochemical preparations and methods of use
880	5,731,334		Method for treating cancer using taxoid onium salt prodrugs
881	5,728,707		Treatment and prevention of primary and metastatic neoplasms with salts of aminoimidazole carboxamide
882	5,728,680		Methods for normalizing numbers of lymphocytes
883	5,725,804		Non-crosslinked protein particles for therapeutic and diagnostic use
884	5,719,265		Polymer-bound paclitaxel derivatives
885	5,719,177		Taxane derivatives
886	5,716,981		Anti-angiogenic compositions and methods of use
887	5,705,508		Anti-tumor compounds, pharmaceutical compositions, methods for preparation thereof and for treatment
888	5,703,247		2-Debenzoyl-2-acyl taxol derivatives and methods for making same
889	5,703,117		Hydrolysis-promoting hydrophobic taxane derivatives
890	5,700,669		Enzymatic hydrolysis method for the conversion of C-7 sugar to C-7 hydroxyl taxanes
891	5,693,666		6,7-modified paclitaxels
892	5,688,992		O-malonyltryrosyl compounds, O-malonyltryrosyl compound-containing peptides, and use thereof
893	5,688,977		Method for docetaxel synthesis
894	5,684,175		C-2' hydroxyl-benzyl protected, N-carbamate protected (2R, 3S)- 3-phenylisoserine and production process therefor
895	5,683,715		Taxane-containing phosphatidylcholine liposomes
896	5,681,847		Methods of using discodermolide compounds
897	5,681,846		Extended stability formulations for paclitaxel
898	5,679,807		Preparation of taxol and docetaxel through primary amines
899	5,677,468		Artemisinin dimer compounds having anticancer activity
900	5,675,025		Paclitaxel synthesis from precursor compounds and methods of producing the same

No. 1 - 100 / 101-200 / 201 - 300 / 301 - 400 / 401 - 500 / 501 - 600 / 601 - 700 / 701 - 800 / 801 - 900 / 901 -939 /